Our Sustainability Pillars

Our sustainability commitment ensures Early Access Care’s everyday actions generate positive impact on the environment and society. At Early Access Care we are passionate about improving global health and well-being and promoting global sustainability.

Responsibility graphic sustainability

Early Access Care’s sustainability and social practices within the United Nations Sustainability Development Goals framework allows us to better convey our commitments to patients, caregivers, society, local communities and the planet.

Corporate Social Responsibility

In 2023 we made meaningful progress across our three sustainability pillars - Environmental, Social and Governance (ESG) - and underwent a rigorous independent assessment of our Corporate Social Responsibility (CSR) management with EcoVadis. The EcoVadis methodology is based on a framework of 21 CSR criteria grouped into 4 core themes – environment, labor and human rights, ethics, sustainable procurement. In 2023 Early Access Care was awarded a Bronze EcoVadis medal in recognition of sustainability achievement. We have more exciting strategic initiatives underway to advance our sustainability commitment.

Csr 1024x1024

In 2023 Early Access Care was awarded a Bronze EcoVadis Medal, placing us among the top companies assessed by EcoVadis.

We recognize the interconnected nature of doing business, and our responsibility to our customers, suppliers, work colleagues, communities and the environment. This inherent responsibility is the basis of our sustainability platform which enables us to drive positive change every day by embedding it throughout our business. Our everyday actions underpin our commitment to sustainability and the impacts that over time will create a better world.

Early Access Care’s mission is to accelerate access to investigational products to patients in need. We’re passionate about what we do and approach each request with urgency, facilitating ethical Sponsor medications to treat seriously ill patients when no other treatments are available. We do this through lawful ‘compassionate use’ pathways.

Want to learn more about our Expanded Access Capabilities?

Contact Us